Morgan Keegan is out with its report today on HCP HCP, maintaining Outperform.
In its report, Morgan Keegan writes, "HCP is the best-diversified healthcare REIT. Management has identified growth opportunities across asset classes through direct ownership, debt investments, and institutional joint ventures, with a focus on high-quality assets. As a result, despite being the largest healthcare REIT, we expect it to be one of the faster-growing. We project 4%-6% long-term FFO and FAD growth."
Morgan Keegan maintains a $4 PT on HCP.
Shares of HCP closed Tuesday at $34.47, down 0.49% from Monday's close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in